Social Anxiety Disorder — Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder
Citation(s)
American Psychiatric Association Diagnostic and statistical manual, 4th edn, Text Revision (DSM-IV-TR). American Psychiatric Association, Washington. 2000.
Goldin PR, Morrison AS, Jazaieri H, Heimberg RG, Gross JJ Trajectories of social anxiety, cognitive reappraisal, and mindfulness during an RCT of CBGT versus MBSR for social anxiety disorder. Behav Res Ther. 2017 Oct;97:1-13. doi: 10.1016/j.brat.2017.06.
Heimberg RG, Becker RE Cognitive-behavioral group therapy for social phobia: Basic mechanisms and clinical strategies. Guilford Press; 2002.
Hope DA, Heimberg RG, Turk CL Managing social anxiety: A cognitive-behavioral therapy approach. Treatments That Work; 2010.
Kabat-Zinn J Mindfulness meditation: Health benefits of an ancient Buddhist practice. In D. Goleman & J. Gurin (Eds.), Mind/Body Medicine (pp. 259-275). Yonkers, NY: Consumer Reports Books, 1993.
Liebowitz MR Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141-73.
Stahl B, Goldstein E A mindfulness-based stress reduction workbook. New Harbinger Publications; 2010 Mar 1.
fMRI of Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
